NCT04099459

ORCA Study: Osteoarthritis and Risks Associated With the Consumption of NSAIDs

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,250 (estimated)
• Sponsor: Scandinavia Pharma · Industry
• Sex: All
• Age: 38 Years
• Healthy volunteers: Not accepted

Summary

Cross-sectional epidemiological study in patients with diagnosis of osteoarthritis (OA) in order to evaluate risk factors associated with the use / prescription of non-steroidal anti-inflammatory drugs (NSAID).

Detailed description

OBJECTIVE: To evaluate the presence of risk factors associated with the use / prescription of non-steroidal anti-inflammatory drugs (NSAID) in patients diagnosed with osteoarthritis (OA). MATERIALS AND METHODS: A multicentric, cross-sectional epidemiological study, will be carried out in patients ≥ 38 years of age, with a previous diagnosis of primary or secondary OA, according to criteria of the American College of Rheumatology (ACR). The presence of at least one risk factor for the use / prescription of NSAIDs is the main variable. The secondary variables to be evaluated include: Demographical characterization of the patients, current disease status (level of pain and functional limitation), treatment (s) used (related or not to OA) and events side effects associated with the treatment (s). The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach.

Conditions

• Osteoarthritis

Timeline

• Start date: 2019-06-10
• Primary completion: 2023-12-01
• Completion: 2024-07-01
• First posted: 2019-09-23
• Last updated: 2019-09-23

Locations

1 site across 1 country: Colombia